Product Description: NLRP3-IN-34 (Compound T10) is an inhibitor for NLRP3 inflammasome. NLRP3-IN-34 inhibits ROS production, NLRP3 inflammasome-dependent IL-1β production (IC50 is 0.48 μM in cells J774A.1), and inhibits pyroptosis. NLRP3-IN-34 exhibits anti-inflammatory activity against DSS-induced peritonitis[1].
Applications: COVID-19-immunoregulation
Formula: C26H22O6
References: [1]Chen H, et al., Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors. Bioorg Med Chem Lett. 2024 May 15;104:129725.
CAS Number: 1392502-55-4
Molecular Weight: 430.45
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: NOD-like Receptor (NLR)